WAYL.CN - Wayland Group Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.7400
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.7400
Open0.0000
Bid0.8000 x 0
Ask0.8000 x 0
Day's Range0.7400 - 0.7400
52 Week Range0.6400 - 2.6400
Volume0
Avg. Volume0
Market Cap67.82M
Beta (3Y Monthly)3.30
PE Ratio (TTM)N/A
EPS (TTM)-0.3530
Earnings DateJul 4, 2019 - Jul 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Wayland Group Receives $5 million Bridge Loan From Cryptologic Corp.

    TORONTO, Aug. 09, 2019 -- Wayland Group (CSE:WAYL) (“Wayland”) and Cryptologic Corp. (CSE: CRY) (“Cryptologic”) are pleased to announce that Wayland has now received the.

  • GlobeNewswire

    Cryptologic Corp. Announces Proposed Acquisition of Canadian Assets of Wayland Group

    Cryptologic Corp., currently a leading cryptocurrency miner (CSE:CRY) (the "Company" or “Cryptologic”) is pleased to announce that it has entered into a non-binding letter of intent with Wayland Group (CSE:WAYL) (“Wayland”), a vertically integrated cultivator and processor of cannabis, with production facilities in Langton, Ontario (the “Facilities”) where it operates a cannabis cultivation, extraction, formulation and distribution business under federal licenses from the Government of Canada, relating to a proposed acquisition of Wayland’s Canadian business, including its Langton, Ontario production facilities, and the assumption of liabilities related to Wayland’s Canadian business. Wayland has agreed to a binding exclusivity period until September 15, 2019, or such later date as each of Wayland and Cryptologic mutually agree, during which time the parties will endeavor to negotiate and enter into a binding definitive agreement in connection with the proposed acquisition.

  • GlobeNewswire

    Wayland Enters Non-Binding LOI to Sell Canadian Business to Cryptologic Corp.

    Obtains Commitment for Cdn$5 million Bridge Loan From Cryptologic Negotiating Second Phase of Transfer of International Business to ICC International Cannabis Corp. Intends.

  • GlobeNewswire

    Wayland Group Closes Transaction with ICC International Cannabis Corp.

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of a 49.9% interest in Maricann B.V. (“Wayland International”), to ICC International Cannabis Corp. (WRLD-U.CN) (8K51.F) (KNHBF) (“ICC”) pursuant to the terms of an amended and restated transaction agreement and related subscription agreement. Wayland now beneficially owns approximately 246,614,000 shares of ICC representing approximately 37% of the outstanding ICC shares following closing on a fully diluted basis. Under the terms of the agreement, ICC is expected to subsequently acquire a 49.9% interest in the balance of Wayland’s international portfolio of assets and, upon completion of that acquisition, Wayland would beneficially own an aggregate of 300,000,000 ICC shares, representing an ownership interest in ICC of approximately 41.7%.

  • GlobeNewswire

    Wayland Group provides Clarification on ICC Transaction

    The Company understands that ICC International Cannabis Corp. will retract the erroneous announcement on this subject that was made early today. Wayland is a vertically integrated cultivator and processor of cannabis.

  • GlobeNewswire

    Wayland Group Confirms “BfARM” award for German Cannabis production

    DEMECAN is awarded three lots of thirteen total, which makes DEMECAN one of three companies globally to achieve a cannabis license for domestic production in Germany, out of 79 applicants. DEMECAN will now begin production within Wayland’s Ebersbach facility, following completion of upgrades to quality and security systems. Additionally, Wayland GmbH has received its narcotics license from the Bundesopiumstelle, the narcotics division of BfArM.

  • CNW Group

    IIROC Trading Halt - WAYL

    IIROC Trading Halt - WAYL

  • GlobeNewswire

    Wayland Addresses Transaction with ICC International Cannabis Corp.

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially affect the Company’s sale of a 49.9% interest in its international asset and license portfolio to ICC International Cannabis Corp (the “Transaction”). Wayland is of the opinion that the Company’s delay in annual filings will not impede closing timeline of the Transaction. Wayland is a vertically integrated cultivator and processor of cannabis.

  • GlobeNewswire

    Wayland Group Confirms Delay in Annual Filings; Expects Issuance of Cease Trade Order

    Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it will be delayed in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after today’s filing deadline.  The additional time is required to permit the Company and its auditors, MNP LLP, to complete work and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its advisors are working diligently to complete such work and enquiries and the Company intends to make the Required Filings as soon as possible.

  • GlobeNewswire

    Wayland Group Announces Anticipated Delay in Annual Filings

    Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after the April 30, 2019 filing deadline. The additional time is required to permit the Company’s auditors, MNP LLP, to complete its review and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its auditors are working diligently, and the Company intends to make the Required Filings as soon as possible and it expects to make these filings by no later than June 14, 2019.

  • GlobeNewswire

    REPEAT - Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019.  Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.

  • GlobeNewswire

    REPEAT - International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group

    ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.

  • GlobeNewswire

    Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (8K51.F) (WLDCF) (“ICC”). The terms of the definitive agreement are consistent with the Letter of Intent that was announced on January 15, 2019.  Wayland will receive 300,000,000 shares of ICC under the agreement, representing approximately 35% of the current outstanding ICC shares on a fully diluted basis. Wayland is also pleased to announce that Matthew McLeod, the current General Counsel and Vice President Operations and Compliance, has been appointed as President effective immediately.

  • GlobeNewswire

    International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group

    ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international asset and license portfolio. Under the terms of the definitive agreement, International Cannabis will issue Wayland 300,000,000 shares in the capital of ICC, representing approximately 38% of the current outstanding ICC shares on a fully diluted basis.

  • GlobeNewswire

    Wayland Provides Clarification on Recent German Tender Update

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like to clarify that Wayland’s joint venture with DEMECAN GmbH (“DEMECAN”) received a score of 60/60 for quality and 40/40 for pricing in the original tender process from early in 2018. Notwithstanding the challenge to the most current tenders described in the Update, the Company is confident that DEMECAN will be successful, and will be awarded the 3 lots for production.

  • GlobeNewswire

    Wayland Provides Update on German Tender Process

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Wayland, through its joint venture with DEMECAN GmbH (“DEMECAN”), was originally selected by BfArM to receive three licenses to produce medical cannabis in Germany. Wayland’s quality concept received 60 out of 60 points for quality and 40 out of 40 points for price.

  • GlobeNewswire

    Wayland Group Announces Facility Drawdown

    TORONTO, April 12, 2019 -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the fifth.

  • GlobeNewswire

    Wayland Group Announces Changes to the Board of Directors

    Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announces the following change to its Board of Directors. Due to personal reasons, Rudi Hilti has resigned as Director of Wayland Group Corp. Mr. Hilti’s responsibilities at his own commercial and non-commercial enterprises have increased to a level that would compromise his time and effectiveness as a board member of the Company. Wayland would like to thank Rudi for his contributions to the Company and wishes him well in his future endeavors.

  • CNW Group

    IIROC Trade Resumption - WAYL

    IIROC Trade Resumption - WAYL

  • GlobeNewswire

    Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly growing German patient population. The Company is one of three groups that have been selected and is subject to a review period, after which a final decision will be made no earlier than April 17, 2019. From the beginning, the market opportunity for medical cannabis in Germany has been a key part of Wayland’s global growth strategy.

  • GlobeNewswire

    REPEAT - International Cannabis and Wayland Confirm Intent to Finalize Transaction

    VANCOUVER, British Columbia, March 11, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) ("ICC" or “International Cannabis” or the “Company”) is.

  • GlobeNewswire

    International Cannabis and Wayland Confirm Intent to Finalize Transaction

    VANCOUVER, British Columbia, March 11, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) ("ICC" or “International Cannabis” or the “Company”) is.